NASA’s experimental X-59 supersonic aircraft was spotted over Fort Worth, Texas, while en route to Kennedy Space Center in Florida. The aircraft is part of NASA’s Quesst mission, which aims to demonstrate supersonic flight with quieter sonic booms.

One year. New heights. Faster speeds. ✈️ Since its first flight on Oct. 28, 2025, NASA's X-59 has continued pushing the boundaries of aviation. See how far we've come in just one year! #NASAaero# #Quesst#

Questions remain about who is leading a taxpayer-funded West Baltimore development authority after information identifying its board members and staff disappeared from its website, while newly obtained public records reveal previous connections between the organization and former Baltimore City Council President Nick Mosby. MORE DETAILS:

Quest 3 of AI Quests is officially live! 🧠✨ Inspired by over a decade of our connectomics and neuroscience research, "Polar Peaks" invites students to step into the shoes of researchers mapping neural pathways in the brain. Created in collaboration with the Stanford Accelerator for Learning, the quest shows teens how human judgment shapes responsible AI. Learn more:

Question for @OpenAI users: Is it normal that installed skills are only usable in ChatGPT Work but not in Chat? I've created and uploaded the skill myself. I can use it in Work, but in Chat it says it doesn't see the skill. 🤔

QUEST DIAGNOSTICS $DGX Q3’26 EARNINGS HIGHLIGHTS 🔹 Revenue: $3.10B (Est. $3.05B) 🟢; +10.0% YoY 🔹 Adj. EPS: $3.00 (Est. $2.86) 🟢; +15.4% YoY 🔹 GAAP EPS: $2.78; +28.7% YoY Raises FY26 Guide: 🔹 Revenue: $12.07B-$12.11B (Est. $12B) 🟢 🔹 Adj. EPS: $11.25-$11.35 (Est. $11.19) 🟢 🔹 GAAP EPS: $10.21-$10.31 🔹 Operating Cash Flow: ~$1.90B 🔹 Capex: ~$550M Cash Flow: 🔹 Operating Cash Flow: $611M; +8.8% YoY 🔹 Capex: $166M; +15.0% YoY Other Q3 Metrics: 🔹 Adj. Oper Income: $517M (Est. $487M) 🟢 🔹 Adj. Oper Margin: 16.7% 🔹 Requisition Volume: +14.5% YoY 🔹 Organic Requisition Volume: +14.4% YoY 🔹 Revenue per Requisition: -4.2% YoY Announcements: 🔹 Quest laboratory test panels with over 50 biomarkers will be available through Apple Health later this year 🔹 Definitive agreement to acquire select outreach lab assets from a leading health system in the Northeastern U.S. 🔹 Launched a new AD-Detect test panel with pTau217, amyloid beta and APOE 🔹 Advanced Project Nova to the solutions-build phase; first lab deployment expected in fall 2027 Comments: 🔸 “With these growth trends and our strong performance, we are raising our revenue and EPS guidance for the full year.”